Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a
photochemical reaction between a light activatable molecule or photosensitizer, light, and�…

Advancements in the prevention, diagnosis, and treatment of cancer have contributed to
improved survival, better quality of life, and declining death rates in the United States. With�…

Background Most patients with locally advanced, unresectable, non–small-cell lung cancer
(NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy�…

Purpose Although intensity-modulated radiation therapy (IMRT) is increasingly used to treat
locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional�…

Background Phase 3 clinical data has shown higher proportions of patients with objective
response, longer response duration, and longer overall survival with nivolumab versus�…

Lung cancer is the leading cause of cancer-related death. The identification of epidermal
growth factor receptor (EGFR) somatic mutations defined a new, molecularly classified�…

Non-small cell lung cancer (NSCLC) accounts for> 80% of lung cancer cases and currently
has an overall five-year survival rate of only 15%. Patients presenting with advanced stage�…

Objective To investigate the impact of harmonization on the performance of CT, PET, and
fused PET/CT radiomic features toward the prediction of mutations status, for epidermal�…

Purpose: Treatment of patients with oncogene-addicted cancers with tyrosine kinase
inhibitors (TKI) is biologically and clinically different than with cytotoxic chemotherapy. We�…

Lung cancer is one of the leading causes of cancer-related death worldwide, with nearly 1.8
million-diagnosis and 1.59 million deaths. Surgery, radiotherapy, and chemotherapy in�…